Le Lézard
Classified in: Covid-19 virus
Subjects: Event, Webcast

Badger Meter to Hold Virtual Annual Meeting Due to COVID-19


Badger Meter, Inc. (NYSE: BMI) today announced that it will host its 2020 annual meeting of shareholders virtually due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of meeting participants.

The 2020 annual meeting of shareholders will be held in a virtual format only, via webcast, at 8:30 a.m. CT on April 24, 2020. Shareholders will not be able to attend the 2020 annual meeting in person.

Shareholders at the close of business on the record date, February 28, 2020, are entitled to participate in the annual meeting. To be admitted to the meeting at www.virtualshareholdermeeting.com/BMI2020, shareholders must enter the 16-digit voting control number found on their proxy card, which was part of the proxy materials previously mailed to shareholders.

Please note that the proxy card and voting instruction form included with previously-distributed proxy materials will not be updated to reflect the change from an in-person meeting to a virtual meeting, and may continue be used to vote shares in connection with the annual meeting. For additional information regarding how shareholders may access, vote and participate in the virtual annual meeting, please refer to the Company's supplemental proxy materials filed today with the Securities and Exchange Commission.

Whether or not shareholders plan to attend the virtual-only annual meeting, Badger Meter urges shareholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.

About Badger Meter

Badger Meter is an innovator in flow measurement, control and communications solutions, serving water utilities, municipalities, and commercial and industrial customers worldwide. The Company's products measure water, oil, chemicals, and other fluids, and are known for accuracy, long-lasting durability and for providing valuable and timely measurement data. For more information, visit www.badgermeter.com


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: